LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Effect of Dexmedetomidine on Incidence of Hypertension Following Repair of Coarctation of the Aorta.

Abarintos, Hope Mae L / Kapuscinski, Christine A / Wheaton, Taylor / Stauber, Sierra D / Swartz, Michael F / Grossman, Madeline / Masri, Sarah / Hutchinson, David J

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

2024  Volume 29, Issue 2, Page(s) 144–150

Abstract: Objective: Recent literature suggests a potential role for dexmedetomidine in reducing the incidence and severity of hypertension following repair of coarctation of the aorta (CoA). The primary aim of this study was to assess the association between ... ...

Abstract Objective: Recent literature suggests a potential role for dexmedetomidine in reducing the incidence and severity of hypertension following repair of coarctation of the aorta (CoA). The primary aim of this study was to assess the association between dexmedetomidine use and the incidence of hypertension following repair of CoA in pediatric patients.
Methods: This was a single-center, retrospective cohort study in patients younger than 19 years who underwent surgical repair of CoA between January 1, 2016, and September 30, 2021. Patients were divided into 2 groups: dexmedetomidine initiation within the first 3 hours after surgery or no dexmedetomidine. The primary outcome was incidence of hypertension within the first 4 to 24 hours after repair. Secondary outcomes included the incidence of hypotension and bradycardia.
Results: A total of 80 patients were included, 25 (31.25%) received dexmedetomidine. Median age at the time of procedure was 26 days (IQR, 13-241) in the dexmedetomidine group and 14 days (IQR, 8-53) in the no dexmedetomidine group (p = 0.014). The primary outcome of hypertension was met in 7 patients (28%) in the dexmedetomidine group and 12 patients (21.8%) in the no dexmedetomidine group, p = 0.547. The only variable found to be associated with the incidence of hypertension was age greater than 30 days at the time of procedure. More patients who received dexmedetomidine experienced bradycardia. There was no difference in the incidence of hypotension.
Conclusions: There was no association between the use of dexmedetomidine and the incidence of -hypertension following repair of CoA in pediatric patients.
Language English
Publishing date 2024-04-08
Publishing country United States
Document type Journal Article
ZDB-ID 3028543-4
ISSN 1551-6776
ISSN 1551-6776
DOI 10.5863/1551-6776-29.2.144
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top